HUMMINGBIRD BIOSCIENCE HOLDINGS

Last Updated: 31 Jan 2025

At Hummingbird Bioscience, we are dedicated to leveraging cutting-edge computational and systems biology approaches to identify and develop innovative biotherapeutics for challenging diseases. Our collaborative, multi-disciplinary approach integrates state-of-the-art techniques throughout the drug discovery and development process, allowing us to streamline the translation of scientific breakthroughs into clinical reality. With a steadfast commitment to rigor, teamwork, and intellectual integrity, we are passionate about accelerating the journey of new drugs from concept to clinic.

Country of registration	Singapore
Registration number	201540910W
Local SIC	64202: Other holding companies
Incorporation date	18 Nov 2015
Company age	10 years 4 months
Official entity type	Public Company Limited By Shares
No. of officers	97

Contact

Address:

51 SCIENCE PARK ROAD, #04-01/11, THE ARIES, Singapore 117586

Access Key Decision Makers

This is the legal entity page of HUMMINGBIRD BIOSCIENCE HOLDINGS. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

HUMMINGBIRD BIOSCIENCE
Singapore
View More
biotech
drug_discovery
biotherapeutics
computational_biology
systems_biology
collaboration
innovation
Others
At Hummingbird Bioscience, we are dedicated to leveraging cutting-edge computational and systems biology approaches to identify and develop innovative biotherapeutics for challenging diseases. Our collaborative, multi-disciplinary approach integrates state-of-the-art techniques throughout the drug discovery and development process, allowing us to streamline the translation of scientific breakthroughs into clinical reality. With a steadfast commitment to rigor, teamwork, and intellectual integrity, we are passionate about accelerating the journey of new drugs from concept to clinic.

This is the legal entity page of HUMMINGBIRD BIOSCIENCE HOLDINGS. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Fiscal/Budgeting Period	October - December
Auditor	ERNST & YOUNG LLP
Revenue	11m - 25m
Financial period end date	31 Dec 2021
Share Capital - Preference shares	USD 159,911,360
Share Capital - Ordinary shares	USD 318,277

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of HUMMINGBIRD BIOSCIENCE HOLDINGS?
Where is HUMMINGBIRD BIOSCIENCE HOLDINGS's headquarter?
What is HUMMINGBIRD BIOSCIENCE HOLDINGS's contact number?
What HUMMINGBIRD BIOSCIENCE HOLDINGS's spending power?
Does HUMMINGBIRD BIOSCIENCE HOLDINGS have a presence in the domain it operates in?